Yenifer Carime Hoyos Mendez

Yenifer Carime Hoyos Mendez

Auto-generated profile, based on publicly available information

Yenifer Carime Hoyos Mendez

Facultad de Medicina, Universidad CES, Medellín, Colombia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2022 in BMJ Paediatrics Open
Verified
Journal Article
Open access
PDF file
VSVanessa Sabella-Jiménez
Vanessa Sabella-Jiménez
YMYenifer Hoyos Mendez
Yenifer Hoyos Mendez
DBDione Benjumea-Bedoya
Dione Benjumea-Bedoya
AEAndrés Felipe Estupiñán-Bohorquez
Andrés Felipe Estupiñán-Bohorquez
JAJorge Acosta-Reyes
Jorge Acosta-Reyes
IFIvan Florez
Ivan Florez
Introduction: Approximately 5%–10% of individuals with untreated latent tuberculosis infection (LTBI) will progress to active tuberculosis (TB). Children are at a higher risk for progression to TB disease than adults. Isoniazid prophylaxis treatment period is long and can cause liver damage. Alternatives to isoniazid, such as rifamycin containing regimens, should be considered for prophylaxis. Previous systematic reviews, with different study designs and data combining results on children and adults, have evaluated the comparative efficacy and harms of LTBI treatment regimens. We aim to determine the effectiveness and safety of all the different regimens available for the treatment of LTBI for children and adolescents less than 18 years of age, contacts of drug-susceptible TB, without HIV infection.Methods and analysis: MEDLINE, Embase and Cochrane Central Register of Controlled Trials will be systematically searched for randomised controlled trials without any language or publication date restriction. Screening and extraction will be performed in duplicate. Risk of bias will be performed in duplicate with Cochrane Risk of Bias tool V.2. Pairwise meta-analysis of direct comparisons and network meta-analyses (NMAs) will be performed. Heterogeneity will be assessed using I2 and Cochrane thresholds. Direct and indirect estimates in an NMA will be combined if justifiable. Subgroups analyses will be performed in different mean age and study year groups. Sensitivity analysis based on the risk of bias will be conducted. Publication bias will be investigated using funnel plots and Egger’s regression test. Grading of Recommendations Assessment, Development and Evaluation (GRADE) criteria will assess certainty of the evidence for the direct comparisons. GRADE approach for NMA will assess the quality of the evidence from the indirect and NMA.Ethics and dissemination: Ethical approval is not required as no primary data are collected. This systematic review will be disseminated in a peer-reviewed journal.PROSPERO registration number: CRD42021271512.

30 October 2024 in Clinical Rheumatology
Verified
Journal Article
Open access
PDF file
DRDiego Fernando Rojas-Gualdrón
Diego Fernando Rojas-Gualdrón
CFCarolina Franco-Salazar
Carolina Franco-Salazar
CGClara Ángela Gómez-Henck
Clara Ángela Gómez-Henck
MMMaria Camila Manrique-Castrillón
Maria Camila Manrique-Castrillón
YHYennifer Carime Hoyos-Méndez
Yennifer Carime Hoyos-Méndez
JDJuan Camilo Díaz-Coronado
Juan Camilo Díaz-Coronado
Objective: To analyze the HRQoL loss associated with self-perceived anxiety/depression in patients with seropositive rheumatoid arthritis (RA). Method: This secondary data analysis is based on a registry-based retrospective follow-up study of patients with seropositive RA treated between August 2014 and January 2023 in ARTMEDICA, Colombia. HRQoL loss and self-perceived anxiety/depression were defined as outcomes. Disease activity (DAS-28) and other patient data were also gathered. Statistical analyses were performed using the ordinal logistic and generalized linear regression models. Results: A total of 3579 patients with a mean follow-up of 2.9 (SD 2.4) years, 85.6% women with a median age at diagnosis of 48.1 (IQR 37.8–57.5) years, and a median of 6.5 (IQR 1.9–14.7) years living with RA were included. At program admission, the median DAS-28 score was 2.8 (IQR 2.1–4.2), and 6.6% of patients reported extreme anxiety/depression. The average HRQoL loss was 3.4 months per year lived with seropositive AR. Among patients with no pain or discomfort, moderate and extreme anxiety/depression were associated with mean HRQoL losses of 2.2 (95% CI − 2.3 to − 2.2) and 4.1 (95% CI − 4.3 to − 3.8) months. In patients with extreme pain/discomfort, these estimations were 0.8 (95% CI − 0.9 to − 0.7) and 1.9 (95% CI − 2.1 to − 1.7) months, respectively. Conclusion: Our study adds to the available body of evidence by clarifying the differential impact of anxiety/depression on HRQoL, depending on the severity of pain. These findings highlight the importance of strengthening mental health care and psychological well-being interventions for patients with RA, regardless of pain or disease activity. Key Points• The average HRQoL loss was 3.4 months per year lived with seropositive AR.• Pain/discomfort rather than disease activity explained the severity of anxiety/depression as well as its associated HRQoL loss.• For patients with extreme pain/discomfort and anxiety/depression, the average HRQoL loss was 8.1 months per year lived with the disease compared to 0.4 months for patients without those impacts.

1 January 2020 in Revista de la Facultad de Ciencias de la Salud Universidad del Cauca
Verified
Journal Article
Open access
PDF file
DGDavid Andrés Muñoz García
David Andrés Muñoz García
DGDiana Catalina Cardona GómEz
Diana Catalina Cardona GómEz
YMYenifer Carime Hoyos Mendez
Yenifer Carime Hoyos Mendez
El vólvulo del sigmoide (VS) es una enfermedad descrita por von Rokitansky en 1836, pero la información más antigua conocida apareció en el papiro de Ebers en Egipto, el documento médico más antiguo preservado, que data de c.1550 AC. El VS es la rotación axial de un segmento del intestino grueso lleno de aire sobre su mesenterio estrecho. Nuestro objetivo fue realizar una revisión en la literatura sobre bibliografía actual del VS. Para ello, se realizó una búsqueda extensa en diferentes bases de datos como: ScienceDirect, ProQuest, La Biblioteca Cochrane Plus, Ebsco, Pubmed, LILACS, Trip Database, SciELO e Intramed con los Descriptores en Ciencias de la Salud: vólvulo, Colon Sigmoide, las cuales aportaron artículos originales, casos y series de casos clínicos, estudios de diagnóstico y tratamiento, capítulos de textos concernientes al manejo de VS. En esta revisión se incluyeron 29 artículos, con información destacable. Se conocen factores de riesgo para desarrollo del VS y el éxito en el tratamiento se relaciona con un diagnóstico temprano y una actuación adecuada. Existe, a pesar de conocer su objetivo de manejo, controversia en el mismo. Una sigmoidectomia diferida se considera un procedimiento eficaz en aquellos pacientes en los que la devolvulación endoscópica ha sido exitosa en primera instancia.